Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
Bringing Innovative Solutions to Healthcare Practitioners.
A Focus on Neurology
Since Moleac was founded, our ambition is to provide new solutions to supplement the therapeutic armamentarium for conditions where significant unmet needs remain. To achieve this goal, we develop natural products according to international standards and commercialize our products worldwide.
Our products are developed by Moleac with scientific excellence and evidence-based approach.
Together with our R&D department and world renowned experts, we have successfully developed and marketed NeuroAiD, the world’s first post-stroke recovery treatment, helping patients to regain functional independence after a stroke or a traumatic brain injury by amplifying endogenous processes of brain repair. NeuroAiD is available in over 30 countries worldwide.
Challenging the Boundaries to The Possible.
OUR INNOVATION TO RECONNECT AFTER A BRAIN INJURY
NeuroAiD is an oral treatment helping patients of brain and spinal cord injuries who suffer from established deficits to recover their functional independence in addition to rehabilitation therapy and exercises. NeuroAiD also supports cognitive functions in Alzheimer’s Disease.
Patients taking NeuroAid yearly
Awards
Countries with Exclusive Partnership
Let’s talk about moleac with noemie & david picard
Moleac in a nutshell. Noemie, 9 years old, gets to know more about Moleac with David Picard, its co-founder and CEO.
Latest News
Join Us at the World Stroke Congress 2024 in Abu Dhabi – Visit Us at Booth 14!
We are thrilled to announce our participation at the World Stroke Congress (WSC) from October 23ʳᵈ to 26ᵗʰ, 2024, in Abu Dhabi.
Clinical Meaningfulness in Alzheimer’s Disease Trials: Key Insights from the EU-US CTAD Task Force Report
Creating a Greener Workplace: Moleac’s Commitment to Sustainability
At Moleac, we are dedicated to sustainability, and we are excited to share the steps we are taking to create an eco-friendly workplace!
Today is World Alzheimer’s Day: Raising Awareness and Helping Patients Reconnect with Their Lives
Today is World Alzheimer’s Day!
Discontinuation of Nutrimore Neuropar – Joint Statement from Moleac and PT Prima Medika Laboratories
ANNOUNCEMENT – INDONESIA
We are pleased to share a joint statement from Moleac Pte. Ltd. and PT Prima Medika Laboratories (PML).
World Alzheimer’s Day: Practical Tips to Support Patients and Caregivers
Shaping the Future of Alzheimer’s Care: Moleac at ASAD 2024 in Malaysia
Moleac was thrilled to participate in ASAD 2024 in Penang, Malaysia, alongside our esteemed partner, EP Plus Group..
Upcoming S.H.A.P.E.S Webinar: Managing Post-Stroke Seizures
Pleased to support S.H.A.P.E.S with their upcoming webinar on Post-Stroke Seizure!
Promoting Stroke Recovery: Highlights from the Stroke Society of the Philippines Annual Convention
Last week, we were delighted to attend the Stroke Society of the Philippines annual convention in Manila..
Empowering Stroke Care: Moleac at the National Scientific Congress on Stroke in Vietnam
Together with EVD Pharma, our distributor in Vietnam, we were grateful to co-sponsor the National Scientific Congress on Stroke held in Ha Long early August..
